Qube Research & Technologies (QRT)
TBI

Qube Research & Technologies (QRT)’s Trueblue TBI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31,426
Closed -$204K – 3942
2025
Q2 		$204K Sell
31,426
-13,234
-30% -$71.3K ﹤0.01% 2907
2025
Q1 		$237K Sell
44,660
-23,574
-35% -$161K ﹤0.01% 2813
2024
Q4 		$573K Sell
68,234
-95,907
-58% -$741K ﹤0.01% 2407
2024
Q3 		$1.3M Sell
164,141
-13,713
-8% -$123K ﹤0.01% 1937
2024
Q2 		$1.83M Buy
177,854
+124,163
+231% +$1.34M ﹤0.01% 1674
2024
Q1 		$672K Buy
+53,691
New +$694K ﹤0.01% 2377
2023
Q4 		– Sell
-3,222
Closed -$47.3K – 4717
2023
Q3 		$47.3K Buy
+3,222
New +$50.2K ﹤0.01% 2887
2022
Q3 		– Sell
-57,717
Closed -$1.03M – 3015
2022
Q2 		$1.03M Buy
+57,717
New +$1.35M 0.01% 1088
2020
Q4 		– Sell
-10,276
Closed -$159K – 2188
2020
Q3 		$159K Sell
10,276
-22,936
-69% -$354K ﹤0.01% 1440
2020
Q2 		$507K Buy
+33,212
New +$493K 0.01% 1105

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TBI Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Trueblue (TBI) in Q3 2025, closing a stake of 31,426 shares — an estimated $204K sold.

Qube Research & Technologies (QRT) first reported a position in TBI in Q2 2020 and held it in 10 quarters. The position peaked at $1.83M in Q2 2024. 108 funds tracked by Wall St. Rank hold TBI as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Trueblue position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 31,426 Trueblue shares in Q3 2025, an estimated $204K.
  • Qube Research & Technologies (QRT) first reported a position in Trueblue in Q2 2020 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Trueblue position peaked at $1.83M in Q2 2024.
  • 108 funds tracked by Wall St. Rank held Trueblue as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.